Markets News

Latest stock market news and real-time market analysis. Track S&P 500, Nasdaq, and Dow Jones movements, sector rotations, and breaking market events.

Vera's TRUTAKNA Cuts Kidney Decline Risk by 76% in Phase 3 Trial
Markets Daniel Marsh

Vera's TRUTAKNA Cuts Kidney Decline Risk by 76% in Phase 3 Trial

Vera Therapeutics announced that TRUTAKNA reduced kidney progression risk by 76% in a confirmatory Phase 3 trial, sending shares up 9.4% in premarket trading.

VERA
Intel's Stock Cushion Thins as AI Trade Wobbles
Markets Daniel Marsh

Intel's Stock Cushion Thins as AI Trade Wobbles

Intel shares closed just $2.19 above their $95 stock sale price after a 5.59% drop, signaling cooling AI enthusiasm and testing the deal's support.

INTC
Future FinTech Stock Surges 179% Despite Lack of Fresh Corporate News
Markets Daniel Marsh

Future FinTech Stock Surges 179% Despite Lack of Fresh Corporate News

Future FinTech Group's stock rocketed 179% on Monday, but no new corporate filings explain the surge. The move follows recent reverse splits and a $30M capital raise.

FTFT
Veea Soars 158% on NovaGen Deal, But Valuation Terms Remain Unclear
Markets Daniel Marsh

Veea Soars 158% on NovaGen Deal, But Valuation Terms Remain Unclear

Veea shares jumped 158% on news of a proposed merger with NovaGen Group, yet the $750 million valuation lacks critical deal terms, leaving investors without a clear target price.

VEEA
Ondas Completes $205M Defense Tech Buy, Ups Ante to $415M
Markets Daniel Marsh

Ondas Completes $205M Defense Tech Buy, Ups Ante to $415M

Ondas closed its $205M acquisition of GATE and Bron, with earn-outs potentially lifting the total to $415M. Shares edged higher in premarket trading.

ONDS
PDS Biotech Surges 60% Despite Heavy Dilution from $11.3M Financing
Markets Daniel Marsh

PDS Biotech Surges 60% Despite Heavy Dilution from $11.3M Financing

PDSB shares surged 60% after a $11.3M PIPE financing, but the deal adds 40M share equivalents, diluting existing holders by over 70%.

PDSB
ASX 200 Hits Three-Month Low as Miners, Banks Weigh
Markets Daniel Marsh

ASX 200 Hits Three-Month Low as Miners, Banks Weigh

Australia's S&P/ASX 200 dropped 0.9% to 8,672.5, its lowest close since June, as losses in miners, banks, and energy shares outweighed gains in tech and healthcare.

BHP RIO CBAUF GLD SLV USO UNG XLE
Futures Recover Modestly as Oil Holds Above $103, Fed Decision Looms
Markets Daniel Marsh

Futures Recover Modestly as Oil Holds Above $103, Fed Decision Looms

U.S. stock futures edged higher Tuesday, recovering slightly from Monday's AI-led slump, but oil above $103 and the Fed's upcoming decision kept gains in check.

SPY QQQ DIA USO GLD SLV XLK XLF XLE
BYD Atto 1 Drops to A$19,990 in Australia, Ties MG3 as Cheapest New Car
Markets Daniel Marsh

BYD Atto 1 Drops to A$19,990 in Australia, Ties MG3 as Cheapest New Car

BYD slashes Atto 1 Essential to A$19,990 drive-away in Australia, tying MG3 as the cheapest new car. The aggressive pricing tests volume strategy amid margin concerns.

EWA
Hancock Prospecting to Acquire 13.5% Stake in White Cliff Minerals
Markets Daniel Marsh

Hancock Prospecting to Acquire 13.5% Stake in White Cliff Minerals

Hancock Prospecting, led by Gina Rinehart, commits A$8.77 million for a 13.5% stake in copper explorer White Cliff Minerals, funding accelerated exploration at the Rae Project.

WCN
Kanzhun Shares Slide 6% on Heavy Volume, Yet No Catalyst Emerges
Markets Daniel Marsh

Kanzhun Shares Slide 6% on Heavy Volume, Yet No Catalyst Emerges

Kanzhun's stock dropped 6% on volume 7.8 times average, but no company announcement explains the move. Recent earnings were strong, and a dividend is pending.

Goldman Sachs Shares Slide 4% Ahead of CEO's Key Capital Markets Address
Markets Daniel Marsh

Goldman Sachs Shares Slide 4% Ahead of CEO's Key Capital Markets Address

Goldman Sachs shares dropped 4% on Monday, setting the stage for CEO David Solomon's Wednesday address where investors will gauge if Q2's stellar results are sustainable or a cyclical peak.

GS BAC